215 related articles for article (PubMed ID: 19188850)
41. Efficacy of a biobehavioral intervention for hot flashes: a randomized controlled pilot study.
Barton DL; Schroeder KCF; Banerjee T; Wolf S; Keith TZ; Elkins G
Menopause; 2017 Jul; 24(7):774-782. PubMed ID: 28266949
[TBL] [Abstract][Full Text] [Related]
42. [Effect of shugan liangxue compound for relieving hot flashes in breast cancer patients].
Sun H; Xue D; Gao F
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Jan; 29(1):30-3. PubMed ID: 19338149
[TBL] [Abstract][Full Text] [Related]
43. Acupuncture for the treatment of hot flashes in breast cancer patients, a randomized, controlled trial.
Hervik J; Mjåland O
Breast Cancer Res Treat; 2009 Jul; 116(2):311-6. PubMed ID: 18839306
[TBL] [Abstract][Full Text] [Related]
44. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial.
Loprinzi CL; Kugler JW; Sloan JA; Mailliard JA; LaVasseur BI; Barton DL; Novotny PJ; Dakhil SR; Rodger K; Rummans TA; Christensen BJ
Lancet; 2000 Dec; 356(9247):2059-63. PubMed ID: 11145492
[TBL] [Abstract][Full Text] [Related]
45. Management of hot flashes in women with breast cancer receiving ovarian function suppression.
Leon-Ferre RA; Majithia N; Loprinzi CL
Cancer Treat Rev; 2017 Jan; 52():82-90. PubMed ID: 27960127
[TBL] [Abstract][Full Text] [Related]
46. The variable response of women with menopausal hot flashes when treated with sertraline.
Kerwin JP; Gordon PR; Senf JH
Menopause; 2007; 14(5):841-5. PubMed ID: 17413648
[TBL] [Abstract][Full Text] [Related]
47. Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial.
Capriglione S; Plotti F; Montera R; Luvero D; Lopez S; Scaletta G; Aloisi A; Serra GB; Angioli R
Gynecol Oncol; 2016 Dec; 143(3):584-588. PubMed ID: 27751589
[TBL] [Abstract][Full Text] [Related]
48. Pilot evaluation of citalopram for the relief of hot flashes.
Barton DL; Loprinzi CL; Novotny P; Shanafelt T; Sloan J; Wahner-Roedler D; Rummans TA; Christensen B; Dakhill SR; Martin LS
J Support Oncol; 2003; 1(1):47-51. PubMed ID: 15352642
[TBL] [Abstract][Full Text] [Related]
49. Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study.
Loibl S; Schwedler K; von Minckwitz G; Strohmeier R; Mehta KM; Kaufmann M
Ann Oncol; 2007 Apr; 18(4):689-93. PubMed ID: 17229772
[TBL] [Abstract][Full Text] [Related]
50. Characterization of hot flashes reported by healthy postmenopausal women receiving raloxifene or placebo during osteoporosis prevention trials.
Cohen FJ; Lu Y
Maturitas; 2000 Jan; 34(1):65-73. PubMed ID: 10687884
[TBL] [Abstract][Full Text] [Related]
51. Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer.
Quella SK; Loprinzi CL; Sloan J; Novotny P; Perez EA; Burch PA; Antolak SJ; Pisansky TM
J Urol; 1999 Jul; 162(1):98-102. PubMed ID: 10379749
[TBL] [Abstract][Full Text] [Related]
52. Raloxifene is associated with less side effects than tamoxifen in women with early breast cancer: a questionnaire study from one physician's practice.
Rohatgi N; Blau R; Lower EE
J Womens Health Gend Based Med; 2002 Apr; 11(3):291-301. PubMed ID: 11988138
[TBL] [Abstract][Full Text] [Related]
53. Pilot evaluation of paroxetine for treating hot flashes in men.
Loprinzi CL; Barton DL; Carpenter LA; Sloan JA; Novotny PJ; Gettman MT; Christensen BJ
Mayo Clin Proc; 2004 Oct; 79(10):1247-51. PubMed ID: 15473404
[TBL] [Abstract][Full Text] [Related]
54. Hot-flashes in breast cancer survivors: effectiveness of low-dosage fluoxetine. A pilot study.
Mariani L; Quattrini M; Atlante M; Galati M; Barbati A; Giannarelli D
J Exp Clin Cancer Res; 2005 Sep; 24(3):373-8. PubMed ID: 16270523
[TBL] [Abstract][Full Text] [Related]
55. Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9.
Barton DL; LaVasseur BI; Sloan JA; Stawis AN; Flynn KA; Dyar M; Johnson DB; Atherton PJ; Diekmann B; Loprinzi CL
J Clin Oncol; 2010 Jul; 28(20):3278-83. PubMed ID: 20498389
[TBL] [Abstract][Full Text] [Related]
56. Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine.
Loprinzi CL; Flynn PJ; Carpenter LA; Atherton P; Barton DL; Shanafelt TD; Rummans TA; Sloan JA; Adjei AA; Mincey BA; Fitch TR; Collins M
J Palliat Med; 2005 Oct; 8(5):924-30. PubMed ID: 16238505
[TBL] [Abstract][Full Text] [Related]
57. Evaluating the role of serotonin in hot flashes after breast cancer using acute tryptophan depletion.
Carpenter JS; Yu M; Wu J; Von Ah D; Milata J; Otte JL; Johns S; Schneider B; Storniolo AM; Salomon R; Desta Z; Cao D; Jin Y; Philips S; Skaar TC
Menopause; 2009; 16(4):644-52. PubMed ID: 19265726
[TBL] [Abstract][Full Text] [Related]
58. Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women.
Stubbs C; Mattingly L; Crawford SA; Wickersham EA; Brockhaus JL; McCarthy LH
J Okla State Med Assoc; 2017 May; 110(5):272-274. PubMed ID: 28649145
[TBL] [Abstract][Full Text] [Related]
59. Pilot evaluation of a stellate ganglion block for the treatment of hot flashes.
Pachman DR; Barton D; Carns PE; Novotny PJ; Wolf S; Linquist B; Kohli S; Smith DR; Loprinzi CL
Support Care Cancer; 2011 Jul; 19(7):941-7. PubMed ID: 20496155
[TBL] [Abstract][Full Text] [Related]
60. Therapy for menopausal symptoms during and after treatment for breast cancer : safety considerations.
Baber R; Hickey M; Kwik M
Drug Saf; 2005; 28(12):1085-100. PubMed ID: 16329712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
